摘要
OBJECTIVE:To summarize the evidence from Traditional Chinese Medicine(TCM)practice in the treatment of coronavirus disease 2019(COVID-19)and provide timely clinical practice guidance.METHODS:The guidelines were developed in accordance with the World Health Organization rapid guideline process.The evidence on TCM for COVID-19 from published guidelines,direct and indirect published clinical evidence,first hand clinical data,and expert experience and consensus were collected.The grading of recommendations assessment,development and evaluation(GRADE)method was used to grade the evidence and make the recommendations.RESULTS:Based on the available evidence,the guidelines recommended 17 Chinese medicines for COVID-19:2 Chinese herbal granules,7 Chinese patent medicines,and 8 Chinese herbal injections.CONCLUSION:As the literature search was conducted on March,any subsequent versions of these guidelines require an up-to-date literature review.We hope that the evidence summary in these guidelines will be helpful in global efforts to address COVID-19.
基金
Supported by National Key Research&Development Program of China Research on the Development and Evaluation of International Standards of Traditional Chinese Medicine(No.2019YFC1712000
2019YFC1712005
2019YFC1712003)
National Science and Technology Major Project"The Belt and Road"Popularization and Application of Traditional Chinese Medicine Clinical Diagnosis and Treatment Project for Infectious Diseases(No.2018ZX10101001-005-003
2018ZX10101001-005-004)。
